Analysts Welcome UnitedHealth CEO Change as Company’s Shares Tank
-
May 16, 2025
While UnitedHealth Group’s stock price declined by more than 15% following the May 13 announcement that the company had replaced CEO Andrew Witty and suspended its financial guidance for this year, Wall Street analysts and other industry observers applauded the move, which they viewed as appropriate considering UnitedHealth’s dismal first-quarter performance.
“United is and always has been heavily focused on quarterly earnings,” Joe Paduda, principal of Health Strategy Associates, LLC, tells AIS Health, a division of MMIT. Profit and loss managers, he adds, “are acutely aware of their numbers and fully understand their obligation is to deliver on their forecast. It is difficult indeed to comprehend how United could have been unaware it would miss projections as badly as it did.”
Read more© 2025 MMIT

The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.